Cours Sienna Biopharmaceuticals, Inc. Other OTC
Actions
SNNAQ
US82622H1086
Recherche biotechnologique et médicale
CA 2017 | - | CA 2018 | - | Capitalisation | 48,12 M 43,79 M |
---|---|---|---|---|---|
Résultat net 2017 | -50 M -45,51 M | Résultat net 2018 | -73 M -66,44 M | VE / CA 2017 | - |
Trésorerie nette 2017 | 74,47 M 67,77 M | Trésorerie nette 2018 | 18,4 M 16,75 M | VE / CA 2018 | - |
PER 2017 |
-3,5
x | PER 2018 |
-0,65
x | Employés | - |
Rendement 2017 * |
-
| Rendement 2018 |
-
| Flottant | 99,54% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | 59 | 27/06/10 | |
Majed Kheir
COO | Chief Operating Officer | 46 | 01/01/16 |
Silvio Traversa
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/12/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Dennis Fenton
BRD | Director/Board Member | 72 | 01/10/16 |
Founder | 59 | 27/06/10 |
Varia. 1 janv. | Capi. | |
---|---|---|
-1,65% | 104 Md | |
+6,75% | 97,47 Md | |
+5,71% | 22,25 Md | |
-12,60% | 21,68 Md | |
-9,70% | 18,2 Md | |
-39,98% | 17,02 Md | |
-10,17% | 16,36 Md | |
+6,12% | 14,39 Md | |
+35,47% | 12,37 Md |